logo
  

Nomura Expresses Regret On Employees' Role In Insider Information Leak

Japanese financial services provider Nomura Holdings, Inc. (NMR) on Friday said it regrets that its employees were found to leak non-public information in some insider trading cases announced by Japan's Securities and Exchange Surveillance Commission.

"Nomura expresses its regret concerning the findings that non-public information was received from Nomura employees in such cases and we sincerely apologize for the trouble this has caused," the company said in its statement.

Japan's Securities regular today recommended that the Prime Minister and the Commissioner of the Financial Services Agency order an administrative monetary penalty against U.S.-based First New York Securities LLC. This is based on a finding that the firm had engaged in insider trading in connection with an equity offering by Tokyo Electric Power Co. in September 2010. Nomura was the underwriter on that offering.

In a separate case, a Third Party Committee established by Sumitomo Mitsui Trust Holdings, Inc. today released a report on insider trading conducted by the former Chuo Mitsui Asset Trust and Banking Co., Limited.

Nomura said it will continue to cooperate fully in the ongoing inspection by the Commission. An extensive internal investigation by a group of outside attorneys is also being conducted in light of the Commission's findings of involvement by Nomura employees, the company noted.

Nomura expects the findings of the internal investigation to be announced by the end of June.

"Nomura takes this matter seriously and will implement improvement measures and disciplinary action in accordance with the results of the internal investigation and the Commission's inspection," the company said.

In Japan, Nomura shares closed today's trading at 268 yen, down 6 yen or 2.19 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT